Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

EU allows use of UCB’s anti-epileptic Vimpat in children

pharmatimesSeptember 25, 2017

Tag: Vimpat , UCB

PharmaSources Customer Service